The increase of resistant bacteria puts a huge pressure on the antimicrobials in current use.
Antimicrobial resistance (AMR) results from antibiotic misuse and abuse over many years …

The current picture of Clostridium difficile infection (CDI) is alarming with a mortality rate
ranging between 3% and 15% and a CDI recurrence rate ranging from 12% to 40%. Despite …

Aims This study aimed to identify the most effective antimicrobial agent from a selection of
essential oils (EO) and investigate its bactericidal properties against Pseudomonas …

Probiotics may offer an attractive alternative for standard antibiotic therapy to treat
Clostridium difficile infections (CDI). In this study, the antibacterial mechanism in vitro of …

Abstract Background Clostridioides difficile (previously Clostridium difficile) is the leading
cause of nosocomial, antibiotic-associated diarrhoea worldwide. Currently, the gold …

Background There is growing interest in faecal microbiota transplantation (FMT) as a
treatment for recurrent Clostridioides difficile infection (CDI), but evidence on the diverse …

Background Clostridioides difficile is the most common causative agent of antibiotic-
acquired diarrhea in hospitalized patients associated with substantial morbidity and …

While combinations of probiotics with antibiotics have exhibited beneficial and adverse
effects in the treatment of Clostridium difficile infection (CDI), no substantive explanation has …

Aims To investigate the mechanisms of action of natural products with bactericidal
(cinnamon root powder, peppermint oil, trans‐cinnamaldehyde, menthol and zingerone) or …

Clostridium difficile infection is a toxin-mediated disease of the colon. C. difficile virulence is
primarily attributed to the production of toxin A and toxin B; thus this study was aimed to …